The Worldwide Clinical Trial Kits Industry is Expected to Reach $2.8 Billion by 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Kits Market Share, Size, Trends, Industry Analysis Report, By Service , By Phase , By Region; Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global clinical trial kits market is anticipated to grow up to USD 2.85 billion by 2030 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The major factors driving the global market include the globalization of clinical trials and rising clinical trial complexity. Remote medical trial services are becoming an essential part of patient satisfaction, safety, and retention. At present, pharmaceutical companies are partnering with global logistics partners in order to provide direct-to-patient services.

The logistics segment is leading the global industry in 2021. This huge market share can be attributed to the growing demand for services in order to simplify the overall logistics process in medical tests. Additionally, pharmaceutical companies are partnering up with global logistics companies in order to provide remote services. This is anticipated to drive the growth of the segment over the coming years.

Based on Phase, the phase III segment is anticipated to dominate the industry in 2021. The basic objective of Phase III is to validate the safety and efficacy of a new medicine or vaccine, confirm the dosage levels, and discover the side effects. The number of clinical tests on humans increases in Phase III. Most of the medicines that passed phase II clinical trials generally fail in Phase III due to the side effects of therapeutic effectiveness.

The growing R&D investments along with the rapid technological advancements are further anticipated to drive the market growth. Alpha Laboratories designs, manufactures and assembles kits such as SpeciSafe packs, 95kPa pouchs, absorbents, Pastette, and others. These new products enable the market players to offer highly competitive pricing along with faster bespoke solutions where required.

Additionally, Q2 Solutions offerings can help in Covid-19 clinical trial, as they offer innovative & technologically advanced solutions such as SARS-CoV-2 virus & antibody detection, SARS-CoV-2 viral genome analysis, immunologic profiling of humans, and vaccine neutralization testing. Thus, these innovative introductions may further support the industry demand across the globe.

The publisher has segmented the clinical trial kits market report on the basis of service, phase, and region:

Clinical Trial Kits, Service Outlook

• Kitting Solutions
• Drug kits
• Sample collection kits
• Logistics
• Warehousing & Storage
• Transportation
• Others

Clinical Trial Kits, Phase Outlook

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trial Kits, Regional Outlook

• North America
• U.S
• Canada
• Europe
• France
• Germany
• UK
• Italy
• Spain
• Netherlands
• Austria
• Asia Pacific
• China
• India
• Japan
• Malaysia
• South Korea
• Indonesia
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Companies Mentioned

• Almac Group
• Alpha Laboratories
• Brooks Life Science
• Cerba research
• Charles River Laboratories
• Clinigen
• LabConnect
• Labcorp Drug Development
• Marken a UPS company
• Patheon
• Precision Medicine Group
• Q2 Solutions

For more information about this report visit https://www.researchandmarkets.com/r/6cw137

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900